This topic contains a solution. Click here to go to the answer

Author Question: Defensive pessimism compared with pessimistic explanatory style is __________. a. the same thing ... (Read 56 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
Defensive pessimism compared with pessimistic explanatory style is __________.
 
  a. the same thing
  b. different because defensive pessimists are not convinced that the worst will continue to happen, but try to prepare in case it does
  c. similar because both are convinced that the worst will continue to happen
  d. different because defensive pessimists are convinced that the worst will continue, while those with pessimistic explanatory style are not

Question 2

Pedro is a pessimist. He is more likely to die __________ than his optimistic brother.
 
  a. of cancer
  b. of heart disease
  c. from accidents or violence
  d. of lung disease



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagnavarro

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: B: different because defensive pessimists are not convinced that the worst will continue to happen, but try to prepare in case it does

Answer to Question 2

Answer: C: from accidents or violence





 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library